Location of Testing Segment Analysis: Laboratory Testing (Largest Segment) vs Point of Care Testing (Fastest-Growing Segment)

Laboratory testing led the STD diagnostics market, accounting for a 75.23% share in 2026. Its dominant position is supported by the ability of centralized laboratories to provide comprehensive diagnostic workflows, standardized testing procedures, and access to sophisticated technologies for identifying sexually transmitted infections. Laboratory-based testing is particularly valuable when accurate differentiation between infections is required or when confirmatory analysis is clinically important. Established laboratory infrastructure, trained personnel, and integration with healthcare systems further reinforce its use across screening and diagnostic programs. The growing emphasis on early detection and appropriate treatment also supports continued reliance on laboratory testing for reliable diagnostic evaluation.

Point of care testing is expected to be the fastest-growing testing-location segment as healthcare systems increasingly prioritize rapid diagnostic decisions and greater accessibility. Point-of-care approaches can provide results closer to the patient, reducing dependence on centralized laboratory workflows and supporting quicker clinical responses. This characteristic is particularly relevant in settings where follow-up access may be limited or where immediate treatment decisions can improve patient management. Greater emphasis on decentralized healthcare delivery, accessible screening, and timely diagnosis is therefore encouraging broader adoption of point-of-care STD testing technologies.

Product Segment Analysis: Consumables (Largest & Fastest-Growing Segment)

The consumables segment dominated the STD diagnostics market and represented a 67.21% share in 2026 while also being the fastest-growing product segment. Its strong position reflects the recurring nature of diagnostic testing, as screening and detection procedures require disposable materials and other single-use components for sample collection, preparation, processing, and analysis. Consumables are integral to both laboratory and decentralized diagnostic workflows, creating demand across a wide range of testing environments. Increasing attention to infection control and the need to maintain reliable testing procedures further support the use of standardized disposable products. At the same time, the expansion of screening activities and adoption of more accessible diagnostic platforms are broadening consumption of testing materials, strengthening the segment's growth prospects within the overall STD diagnostics landscape.